As summarized by Tang et al., CD40-CD40L interactions can suppress immune responses by upregulating immune checkpoint molecules, creating an immunosuppressive environment that enables MM cells to evade immune surveillance [19]. The gene discussed is CD40; the disease is Miyoshi myopathy.